ArticleJournal of pharmacopuncture2026
Antioxidant and Tyrosinase Inhibitory Potential of
Article in Journal of pharmacopuncture, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Oxidative stress contributes to skin damage and hyperpigmentation through excessive melanin production. Tyrosinase plays a central role in melanogenesis by catalyzing the oxidation of tyrosine to melanin precursors. Although several tyrosinase inhibitors are available, their clinical use is limited due to adverse effects. Therefore, identifying safer inhibitors with concomitant antioxidant properties remains of considerable interest. In ethnomedicine, Methods: Here, 80% ethanolic extract of Results: E inhibited UV-induced lipid peroxidation (EC Conclusion: The findings indicate that the biological activities of E likely result from the combined action of multiple phytochemical constituents. These findings support its potential as a source of bioactive compounds for cosmetic and dermatological applications targeting oxidative and pigmentation-related skin alterations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.